한글목차

최근 단일세포 오믹스 시장 규모는 급성장하고 있습니다. 2025년 23억 9,000만 달러에서 2026년에는 27억 8,000만 달러에 이르고, CAGR 16.3%의 성장이 전망되고 있습니다. 지난 수년간의 성장 요인으로는 차세대 시퀀싱 기술의 발전, 학술 연구 자금 증가, 암 연구 이니셔티브의 확대, 세포 불균일성 분석에 대한 수요, 세포 분리 기술의 향상 등을 꼽을 수 있습니다.

단일세포 오믹스 시장 규모는 향후 몇 년간 급성장이 전망되고 있습니다. 2030년에는 52억 7,000만 달러에 이르고, CAGR은 17.4%를 나타낼 전망입니다. 예측 기간 동안의 성장 요인으로는 정밀의료 프로그램 확대, 오믹스 분석에 대한 AI 통합, 제약 분야의 R&D 투자 증가, 임상 진단 분야에서의 채택 확대, 비용 효율적인 단일 세포 플랫폼의 개발 등이 꼽힙니다. 예측 기간 동안 주요 동향으로는 멀티오믹스 접근법 채택 증가, 고해상도 세포 분석에 대한 수요 증가, 종양학 연구에서의 단일 세포 적용 확대, 세포 분리를 위한 마이크로플루이딕스 기술 활용 증가, 단일 세포 분석 워크플로우 표준화 등을 들 수 있습니다.

암 발병률 증가는 향후 몇 년 동안 단일 세포 오믹스 시장의 성장을 뒷받침할 것으로 예측됩니다. 암은 비정상적인 세포가 통제할 수 없을 정도로 증식하여 정상 경계를 넘어 원격 장기로 전이되거나 주변 조직으로 침윤하는 경우, 거의 모든 장기나 조직에서 발생할 수 있는 광범위한 질환군을 말합니다. 단일 세포체 데이터는 암 검출을 위한 바이오마커 식별, 질병 결과 예측, 특정 임상 집단 내 새로운 치료 표적 발굴에 광범위하게 적용되고 있습니다. 예를 들어, 미국 정부 기관인 국립보건원(NIH)에 따르면, 2022년 1월 현재 미국에는 약 1,810만 명의 암 생존자가 있으며, 이 숫자는 2032년까지 2,250만 명으로 증가할 것으로 예측됩니다. 그 결과, 암 부담 증가가 단일세포오믹스 시장 확대를 주도하고 있습니다.

단일 세포 오믹스 시장에서 사업을 전개하는 주요 기업들은 단일 세포 연구 용도를 지원하고 수익 창출을 강화하기 위해 시퀀싱 키트를 포함한 첨단 키트 개발에 주력하고 있습니다. 시퀀싱 키트는 실험실 환경에서 유전자 시퀀싱 워크플로우를 간소화하고 최적화하기 위해 설계된 시약 및 재료 세트입니다. 예를 들어, 차세대 시퀀싱 기술 전문 미국 기업 Singular Genomics Systems는 2023년 2월 G4 시퀀싱 플랫폼용 단일 세포 시퀀싱을 위한 'Max Read 키트'를 발표했습니다. 이 키트는 널리 사용되는 10x Genomics assay와 호환되며, 한 번의 실행으로 4-16개의 샘플을 시퀀싱할 수 있습니다. Max Read 키트는 플로우셀 당 최대 8억 개의 리드를 제공하며, Q30 품질 수준은 80%에서 90%까지 다양합니다. 또한, Singular Genomics는 G4 시퀀싱 플랫폼의 F2 및 F3 플로우셀의 성능 파라미터를 강화하여 특정 용도에서 F3 플로우셀로 런당 최대 1.8억 리드를 달성할 수 있도록 했습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Single-cell omics involves profiling individual cells obtained from heterogeneous cell populations at different cellular stages, enabling detailed analysis of normal development and disease mechanisms at the single-cell level. These approaches are applied to study cellular heterogeneity, identify distinct cell types, investigate diseases, and support therapeutic development.

The key types of single-cell omics products include single-cell genomics, single-cell transcriptomics, single-cell proteomics, and single-cell metabolomics. Single-cell genomics is an advanced method for classifying individual cells, allowing the detection of rare cell types and the characterization of unique cellular features. The technologies used include cell isolation methods, sample preparation techniques, and next-generation sequencing analysis, which are applied across oncology, cell biology, neurology, and immunology. The primary end users include pharmaceutical and biotechnology companies, academic and research institutions, hospital and diagnostic laboratories, and others.

Tariffs have created moderate challenges for the single-cell omics market by increasing costs of imported sequencing instruments, reagents, microfluidic chips, and analytical equipment, impacting overall research budgets and slowing procurement cycles. The effects are most pronounced across single-cell genomics and transcriptomics segments, particularly in regions such as Asia-Pacific and Europe that rely heavily on cross-border trade for advanced laboratory technologies. Academic research organizations and biotechnology firms face higher operational costs, while some suppliers are responding by localizing manufacturing and supply chains. In the long term, tariffs may support regional production capabilities and encourage domestic innovation in single-cell technologies.

The single-cell omics market research report is one of a series of new reports from The Business Research Company that provides single-cell omics market statistics, including single-cell omics industry global market size, regional shares, competitors with a single-cell omics market share, detailed single-cell omics market segments, market trends and opportunities, and any further data you may need to thrive in the single-cell omics industry. This single-cell omics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The single-cell omics market size has grown rapidly in recent years. It will grow from $2.39 billion in 2025 to $2.78 billion in 2026 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be attributed to advancements in next-generation sequencing, increasing academic research funding, growing cancer research initiatives, demand for cellular heterogeneity analysis, improvements in cell isolation technologies.

The single-cell omics market size is expected to see rapid growth in the next few years. It will grow to $5.27 billion in 2030 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to expansion of precision medicine programs, integration of AI in omics analysis, increasing pharmaceutical R&D investments, rising adoption in clinical diagnostics, development of cost-effective single-cell platforms. Major trends in the forecast period include rising adoption of multi-omics approaches, growing demand for high-resolution cellular analysis, expansion of single-cell applications in oncology research, increased use of microfluidics for cell isolation, standardization of single-cell analysis workflows.

The rising prevalence of cancer is expected to support the growth of the single-cell omics market in the years ahead. Cancer includes a broad range of diseases that can originate in nearly any organ or tissue when abnormal cells multiply uncontrollably, cross normal boundaries, and spread to distant organs or infiltrate surrounding tissues. Single-cell omics data is widely applied to identify biomarkers for cancer detection, forecast disease outcomes, and discover new therapeutic targets within defined clinical populations. For example, in May 2024, according to the National Institutes of Health, a US-based government agency, approximately 18.1 million individuals in the United States were living as cancer survivors as of January 2022, and this number is projected to increase to 22.5 million by 2032. Consequently, the increasing cancer burden is driving the expansion of the single-cell omics market.

Key companies operating in the single-cell omics market are focusing on the development of advanced kits, including sequencing kits, to support single-cell research applications and enhance revenue generation. Sequencing kits are bundled sets of reagents and materials designed to simplify and optimize genetic sequencing workflows in laboratory settings. For instance, in February 2023, Singular Genomics Systems, Inc., a US-based company focused on next-generation sequencing technologies, launched Max Read Kits for single-cell sequencing on its G4 Sequencing Platform. These kits are compatible with commonly used 10x Genomics assays and allow sequencing of 4 to 16 samples in a single run. The Max Read Kits provide up to 800 million reads per flow cell with Q30 quality levels between 80% and 90%. Additionally, Singular Genomics enhanced the performance parameters of the G4 Sequencing Platform's F2 and F3 flow cells, enabling up to 1.8 billion reads per run on F3 flow cells for specific applications.

In August 2025, 10x Genomics, a US-based provider of single-cell and spatial biology instruments, consumables, and software, acquired Scale Biosciences for $13.5 million. Through this acquisition, 10x Genomics aims to strengthen its Chromium platform by integrating Scale's scalable single-cell technologies, thereby advancing high-throughput single-cell analysis while improving affordability and accessibility. Scale Biosciences is a US-based company specializing in the development and delivery of single-cell omics solutions.

Major companies operating in the single-cell omics market are Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Thermo Fisher Scientific Inc, Agilent Technologies Inc, Sartorius AG, Illumina Inc, Bio Rad Laboratories Inc, Qiagen NV, Tecan Group Ltd, BGI Genomics Co Ltd, 10x Genomics Inc, Takara Bio Inc, NanoString Technologies Inc, Vizgen, Deepcell, Mission Bio Inc, Standard BioTools Inc, CYTENA GmbH, Single Cell Discoveries

North America was the largest region in the single-cell omics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the single-cell omics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The single-cell omics market includes revenues earned by entities through single-cell sorting and isolation, single-cell sample preparation kits, and related single-cell data analysis software. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Single-Cell Omics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses single-cell omics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for single-cell omics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The single-cell omics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Single-Cell Genomics; Single-Cell Transcriptomics; Single-Cell Proteomics; Single-Cell Metabolomics
• 2) By Technology: Cell Isolation Technologies; Sample Preparation Technologies; Analysis Of Next-Generation Sequencing
• 3) By Application: Oncology; Cell Biology; Neurology; Immunology
• 4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Organizations; Hospital And Diagnostic Laboratories; Other End Users
• Subsegments:
• 1) By Single-Cell Genomics: Whole Genome Sequencing (WGS); Targeted Sequencing; Single-Cell DNA Analysis Kits
• 2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq); Quantitative PCR (qPCR) For Single Cells; Single-Cell Gene Expression Analysis Kits
• 3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics; Antibody-Based Protein Analysis; Single-Cell Protein Analysis Kits
• 4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites; Nuclear Magnetic Resonance (NMR) Metabolomics; Single-Cell Metabolite Profiling Kits
• Companies Mentioned: Danaher Corporation; Merck KGaA; Becton Dickinson and Company; Thermo Fisher Scientific Inc; Agilent Technologies Inc; Sartorius AG; Illumina Inc; Bio Rad Laboratories Inc; Qiagen NV; Tecan Group Ltd; BGI Genomics Co Ltd; 10x Genomics Inc; Takara Bio Inc; NanoString Technologies Inc; Vizgen; Deepcell; Mission Bio Inc; Standard BioTools Inc; CYTENA GmbH; Single Cell Discoveries
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Single-Cell Omics Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Single-Cell Omics Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Single-Cell Omics Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Single-Cell Omics Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Multi-Omics Approaches
  • 4.2.2 Growing Demand For High-Resolution Cellular Analysis
  • 4.2.3 Expansion Of Single-Cell Applications In Oncology Research
  • 4.2.4 Increased Use Of Microfluidics For Cell Isolation
  • 4.2.5 Standardization Of Single-Cell Analysis Workflows

5. Single-Cell Omics Market Analysis Of End Use Industries

• 5.1 Pharmaceutical And Biotechnology Companies
• 5.2 Academic And Research Organizations
• 5.3 Hospital And Diagnostic Laboratories
• 5.4 Contract Research Organizations (CROs)
• 5.5 Government And Public Research Institutes

6. Single-Cell Omics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Single-Cell Omics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Single-Cell Omics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Single-Cell Omics Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Single-Cell Omics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Single-Cell Omics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Single-Cell Omics Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Single-Cell Omics Market Segmentation

• 9.1. Global Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics
• 9.2. Global Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing
• 9.3. Global Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oncology, Cell Biology, Neurology, Immunology
• 9.4. Global Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users
• 9.5. Global Single-Cell Omics Market, Sub-Segmentation Of Single-Cell Genomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Whole Genome Sequencing (WGS), Targeted Sequencing, Single-Cell DNA Analysis Kits
• 9.6. Global Single-Cell Omics Market, Sub-Segmentation Of Single-Cell Transcriptomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• RNA Sequencing (RNA-seq), Quantitative PCR (qPCR) For Single Cells, Single-Cell Gene Expression Analysis Kits
• 9.7. Global Single-Cell Omics Market, Sub-Segmentation Of Single-Cell Proteomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Mass Spectrometry-Based Proteomics, Antibody-Based Protein Analysis, Single-Cell Protein Analysis Kits
• 9.8. Global Single-Cell Omics Market, Sub-Segmentation Of Single-Cell Metabolomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Mass Spectrometry For Metabolites, Nuclear Magnetic Resonance (NMR) Metabolomics, Single-Cell Metabolite Profiling Kits

10. Single-Cell Omics Market Regional And Country Analysis

• 10.1. Global Single-Cell Omics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Single-Cell Omics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Single-Cell Omics Market

• 11.1. Asia-Pacific Single-Cell Omics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Single-Cell Omics Market

• 12.1. China Single-Cell Omics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Single-Cell Omics Market

• 13.1. India Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Single-Cell Omics Market

• 14.1. Japan Single-Cell Omics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Single-Cell Omics Market

• 15.1. Australia Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Single-Cell Omics Market

• 16.1. Indonesia Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Single-Cell Omics Market

• 17.1. South Korea Single-Cell Omics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Single-Cell Omics Market

• 18.1. Taiwan Single-Cell Omics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Single-Cell Omics Market

• 19.1. South East Asia Single-Cell Omics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Single-Cell Omics Market

• 20.1. Western Europe Single-Cell Omics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Single-Cell Omics Market

• 21.1. UK Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Single-Cell Omics Market

• 22.1. Germany Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Single-Cell Omics Market

• 23.1. France Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Single-Cell Omics Market

• 24.1. Italy Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Single-Cell Omics Market

• 25.1. Spain Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Single-Cell Omics Market

• 26.1. Eastern Europe Single-Cell Omics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Single-Cell Omics Market

• 27.1. Russia Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Single-Cell Omics Market

• 28.1. North America Single-Cell Omics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Single-Cell Omics Market

• 29.1. USA Single-Cell Omics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Single-Cell Omics Market

• 30.1. Canada Single-Cell Omics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Single-Cell Omics Market

• 31.1. South America Single-Cell Omics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Single-Cell Omics Market

• 32.1. Brazil Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Single-Cell Omics Market

• 33.1. Middle East Single-Cell Omics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Single-Cell Omics Market

• 34.1. Africa Single-Cell Omics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Single-Cell Omics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Single-Cell Omics Market Regulatory and Investment Landscape

36. Single-Cell Omics Market Competitive Landscape And Company Profiles

• 36.1. Single-Cell Omics Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Single-Cell Omics Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Single-Cell Omics Market Company Profiles
  • 36.3.1. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Agilent Technologies Inc Overview, Products and Services, Strategy and Financial Analysis

37. Single-Cell Omics Market Other Major And Innovative Companies

• Sartorius AG, Illumina Inc, Bio Rad Laboratories Inc, Qiagen NV, Tecan Group Ltd, BGI Genomics Co Ltd, 10x Genomics Inc, Takara Bio Inc, NanoString Technologies Inc, Vizgen, Deepcell, Mission Bio Inc, Standard BioTools Inc, CYTENA GmbH, Single Cell Discoveries

38. Global Single-Cell Omics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Single-Cell Omics Market

40. Single-Cell Omics Market High Potential Countries, Segments and Strategies

• 40.1 Single-Cell Omics Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Single-Cell Omics Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Single-Cell Omics Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer